CASC has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Cascadian Therapeutics Inc's sale of investment for the three months ended in Jun. 2016 was $18.36 Mil. It means Cascadian Therapeutics Inc gained $18.36 Mil from selling investments. Cascadian Therapeutics Inc's sale of investment for the trailing twelve months (TTM) ended in Jun. 2016 was $91.51 Mil.
Compared with last quarter ($14.10 Mil in Mar. 2016 ), Cascadian Therapeutics Inc gained more money from selling investments in Jun. 2016 ($18.36 Mil).
Sale of Investments represents cash inflow on the sale of investments in securities.
Cascadian Therapeutics Inc SaleOfInvestment for the trailing twelve months (TTM) ended in Jun. 2016 was 36.036 (Sep. 2015 ) + 23.006 (Dec. 2015 ) + 14.104 (Mar. 2016 ) + 18.362 (Jun. 2016 ) = $91.51 Mil.
Cascadian Therapeutics Inc Annual Data
Cascadian Therapeutics Inc Quarterly Data